Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone (LDN) Therapy for Complex Regional Pain Syndrome (CRPS)
NCT06306157Phase 4Enrolling by invitation
- Sponsor
- Hospital for Special Surgery
- Start
- Jan 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in complex regional pain syndrome (CRPS), sponsored by Hospital for Special Surgery. Started Jan 2024; status: enrolling by invitation.
02
Drugs
naltrexone
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT06306157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306157.